Utopioid (drug class)
Class of opioid analgesics
Utopioid (drug class)
Utopioids are a class of synthetic opioid analgesics that were developed in the 1970s by a team at Upjohn Pharmaceuticals. These compounds are structurally related to the better-known opioid tramadol and are characterized by their potent analgesic effects. Utopioids are primarily used in research settings and have not been widely adopted for clinical use due to their potential for abuse and addiction.
Chemical Structure
Utopioids are characterized by their unique chemical structures, which are distinct from traditional opioids like morphine and fentanyl. The core structure of utopioids typically includes a cyclohexane ring, which is substituted with various functional groups that influence their pharmacological properties.
The most well-known compounds in this class include U-47700, U-48800, and U-49900. These compounds have been studied for their high affinity for the mu-opioid receptor, which is responsible for their analgesic effects.
Pharmacology
Utopioids act primarily as agonists at the mu-opioid receptor, similar to other opioids. This receptor is part of the opioid receptor family, which also includes the delta-opioid receptor and the kappa-opioid receptor. Activation of the mu-opioid receptor leads to analgesia, euphoria, and respiratory depression, which are common effects of opioid drugs.
The potency of utopioids can vary significantly depending on their specific chemical structure. For example, U-47700 is known to be several times more potent than morphine, making it a subject of interest for both therapeutic and illicit use.
Clinical Use and Legal Status
While utopioids have shown potential as powerful analgesics, their clinical use is limited due to concerns about safety and abuse potential. Many utopioids have been classified as Schedule I controlled substances in various countries, indicating that they are considered to have a high potential for abuse and no accepted medical use.
The legal status of these compounds can vary by jurisdiction, and they are often subject to regulation under analog drug laws that control substances similar to known controlled drugs.
Research and Development
Research into utopioids continues, with scientists exploring their potential for pain management and their pharmacological properties. Studies often focus on modifying the chemical structure to reduce side effects and abuse potential while maintaining analgesic efficacy.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD